Life expectancy and cardiovascular mortality in persons with schizophrenia

Harris, 1998, Excess mortality of mental disorder., Br J Psychiatry, 173, 11, 10.1192/bjp.173.1.11

Osby, 2000, Mortality and causes of death in schizophrenia in Stockholm county, Sweden., Schizophr Res, 45, 21, 10.1016/S0920-9964(99)00191-7

Laursen, 2007, Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia., J Clin Psychiatry, 68, 899, 10.4088/JCP.v68n0612

Saha, 2007, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time Arch Gen, Psychiatry, 64, 1123

Laursen, 2011, Life expectancy among persons with schizophrenia or bipolar affective disorder., Schizophr Res, 131, 101, 10.1016/j.schres.2011.06.008

Hennekens, 2005, Schizophrenia and increased risks of cardiovascular disease., Am Heart J, 150, 1115, 10.1016/j.ahj.2005.02.007

Shen, 2011, Increased risks of acute organ dysfunction and mortality in intensive care unit patients with schizophrenia: a nationwide population-based study., Psychosom Med, 73, 620, 10.1097/PSY.0b013e3182280016

Chang, 2011, Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental healthcare case register in London., PLoS One, 6, e19590, 10.1371/journal.pone.0019590

Schmidt, 2011, The impact of substance use disorders on the course of schizophrenia: a 15-year follow-up study-dual diagnosis over 15 years., Schizophr Res, 130, 228, 10.1016/j.schres.2011.04.011

Phutane, 2011, Cardiovascular risk in a first-episode psychosis sample: a critical period for prevention Schizophr, Res, 127, 257

Strom, 2011, Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)., Am J Psychiatry, 168, 193, 10.1176/appi.ajp.2010.08040484

Kang, 2011, Lower mortality among stroke patients with schizophrenia: a nationwide population-based study., Psychosom Med, 73, 106, 10.1097/PSY.0b013e3181fdc2c9

Laursen, 2011, Heart disease treatment and mortality in schizophrenia and bipolar disorder: changes in the Danish population between 1994 and 2006., J Psychiatr Res, 45, 29, 10.1016/j.jpsychires.2010.04.027

Thomas, 2010, Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)., Acta Psychiatr Scand, 122, 345, 10.1111/j.1600-0447.2010.01563.x

Brown, 2010, Twenty-five year mortality of a community cohort with schizophrenia., Br J Psychiatry, 196, 116, 10.1192/bjp.bp.109.067512

Kelly, 2010, Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study., J Clin Psychiatry, 71, 304, 10.4088/JCP.08m04718yel

De, 2010, Do antipsychotic medications reduce or increase mortality in schizophrenia A critical appraisal of the FIN-11 study., Schizophr Res, 117, 68, 10.1016/j.schres.2009.12.029

Mitchell, 2011, Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis., Br J Psychiatry, 198, 434, 10.1192/bjp.bp.109.076950

Lawrence, 2010, The epidemiology of excess mortality in people with mental illness., Can J Psychiatry, 55, 752, 10.1177/070674371005501202

Munk-Jorgensen, 2010, Physical illness in persons with schizophrenia: time for action., Indian J Med Res, 132, 353

Bradley, 2010, A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality., J Psychopharmacol, 24, 91, 10.1177/1359786810385491

Mitchell, 2010, Do deficits in cardiac care influence high mortality rates in schizophrenia A systematic review and pooled analysis., J Psychopharmacol, 24, 69, 10.1177/1359786810382056

Wildgust, 2010, Are there modifiable risk factors which will reduce the excess mortality in schizophrenia J, Psychopharmacol, 24, 37, 10.1177/1359786810384639

Bushe, 2010, Mortality in schizophrenia: a measurable clinical endpoint., J Psychopharmacol, 24, 17, 10.1177/1359786810382468

Wildgust, 2010, The paradox of premature mortality in schizophrenia: new research questions., J Psychopharmacol, 24, 9, 10.1177/1359786810382149

Raedler, 2010, Cardiovascular aspects of antipsychotics., Curr Opin Psychiatry, 23, 574, 10.1097/YCO.0b013e32833f46c9

Trangle, 2010, Minnesota 10 by 10. Reducing morbidity and mortality in people with serious mental illnesses., Minn Med, 93, 38

Heald, 2010, Physical health in schizophrenia: a challenge for antipsychotic therapy., Eur Psychiatry, 25, S6, 10.1016/S0924-9338(10)71700-4

Blasco-Fontecilla, 2010, Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality Possible role of 5-HT2A receptor blockade., Schizophr Res, 119, 160, 10.1016/j.schres.2009.12.005

Angst, 2002, Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia., Schizophr Res, 57, 5, 10.1016/S0920-9964(02)00328-6